Visit Share Talk TV for a chance to catch up with the previous weeks stock market interviews, and articles made public across multiple platforms including Share Talk, Vox Markets, Proactive Investors. We will expand
Visit Share Talk TV for a chance to catch up with the previous weeks stock market interviews, and articles made public across multiple platforms including Share Talk, Vox Markets, Proactive Investors. We will expand
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company developing sulforaphane based medicines for the treatment of multiple diseases, announces preclinical data demonstrating that SFX-01 was effective in
We begin our weekly small company report with news that Yu Group PLC’s (LON:YU.) business update was well received by the market.
Evgen Pharma plc (AIM: EVG), a clinical stage drug development company, announces further progress and an update on clinical trial plans for SFX-01 in glioblastoma (“GBM”).
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview in this video charting update.
Evgen Pharma plc (AIM: EVG), a clinical stage drug development company, is pleased to announce that all necessary regulatory approvals have now been received for the STAR trial (SFX-01 treatment
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this video charting update.
Zak Mir highlights some of the most followed stocks on the small-cap London market and gives an overview of the fundamentals in this charting update. Here is our pick of the
Another weekend rolls around and we are in for a busy few weeks ahead, following on the excellent Cobra Resources Investor Presentation.
Evgen Pharma plc (AIM: EVG), the clinical stage drug development company, is delighted to announce participation in the recently notified funding initiative for COVID-19 clinical trials by the medical research
The University of Dundee is leading the clinical trial of a new anti-inflammatory drug it is hoped may reduce instances of severe lung damage and death in Covid-19 patients.